The in vitro effect of lentinan in inducing activation of killer cells and cytotoxic macrophages has been examined. Human peripheral blood mononuclear cells were cultured with lentinan for 2, 4 and 8 days. After 4 days cytotoxicity was increased 4% by lentinan <1,000 ng/ml. After 8 days, it was increased 12% by 25 and 1,000 ng/ml lentinan. The phenotype of the killer cells induced by lentinan was CD2+, CD16+ and CD56+, suggesting that they were natural killer cells. Macrophages separated from the spleens of 6 patients with gastric cancer were cultured with lentinan for 7 days, and their cytotoxicity increased 19%. The optimal concentration of lentinan was from 25 to 100 ng/ml.
The findings suggest that the antitumour effect of lentinan is due to the activation of killer cells in vivo, because the optimal concentration of lentinan for the induction of killer cells in vitro was equivalent to the plasma concentration obtained after clinical doses of this agent.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Brooks CG, Holscher M, Urdal D (1985) Natural killer activity in cloned cytotoxic T lymphocytes: regulation by interleukin 2, interferon, and specific antigen. J Immunol 135: 1145–1152
Timonen T, Ortaldo JR, Stadler BM, Sharrow SO, Herbermann RB (1982) Cultures of purified human natural killer cells: growth in the presence of interleukin 2. Cell Immunol 72: 178–185
Itoh K, Shiiba K, Shimizu Y, Suzuki R, Kumagai K (1985) Generation of activated killer (AK) cells by recombinant interleukin 2 (rIL-2) in collaboration with interferon-γ (IFN-γ). J Immunol 134: 3124–3129
Djeu JY, Heinbaugh JA, Holden HT, Herbarmann RB (1979) Augmentation of mouse natural killer cell activity by interferon and interferon inducers. J Immunol 122: 175–181
Yamaue H, Katsumi M, Tabuse K, Tabuse Y, Kuribayashi K, Nishihara T, Saito K (1987) Induction of activated natural killer cells from murine spleen cells primed in vivo and subsequently challenged in vitro with the streptococcal preparation OK432. Cancer Immunol Immunother 25: 169–174
Herbermann RB, Ortaldo JR, Bennard GY (1979) Augmentation by interferon of human natural and antibody dependent cell mediated cytotoxicity. Nature 277: 221
Hamuro J, Chihara G (1984) Lentinan, a T-cell-oriented immunopotentiator-its experimental and clinical applications and possible mechanism of immune modulation. Immune modulation agents and their mechanisms. Marcel Dekker, USA
Chihara G, Maeda Y, Hamuro J, Sasaki T, Fukuoka F (1969) Inhibition of mouse sarcoma 180 by polysaccharides from Lentinus edodes (Berk.) Sing. Nature 222: 637–638
Fachet J, Chihara G (1980) Effect of lentinan on tumor growth in murine allogeneic and syngeneic hosts. Int J Cancer 25: 371–376
Sakamoto J, Momoi T, Imaizumi M (1979) The effect of intravenous hyperalimentation on cell mediated immunity. Jap J Surg 9: 89–94
Uchida A, Micksche M (1982) Autologous mixed lymphocyte reaction in the peripheral blood and pleural effusions of cancer patients. J Clin Invest 70: 98–104
Yajima Y, Fukuda I, Otsuki M, Suzuki H, Ota S, Ishii M, Mori K, Goto Y (1985) Endotoxemia in liver disease: detection by a quantitative assay using chromogenic substrate with perchloric acid pretreatment. Tohoku J Exp Med 147: 411–419
Suga T, Shiio T, Maeda Y, Chihara G (1984) Antitumor activity of lentinan in murine syngeneic and autochthonous hosts and its suppressive effect on 3-methylcholanthrene-induced carcinogenesis. Cancer Res 44: 5132–5137
Talmadge JE, Herberman RB (1986) The preclinical screening laboratory: Evaluation of immunomodulatory and therapeutic properties of biological response modifiers. Cancer Treat Rep 70: 171–182
Yamaue H, Tanimura H, Iwahashi M, Tani M, Tsunoda T, Tabuse K, Kuribayashi K, Saito K (1989) Role of interleukin-2 and interferon-γ in induction of activated natural killer cells from mice primed in vivo and subsequently challenged in vitro with the streptococcal preparation OK432. Cancer Immunol Immunother 29: 79–86
Nakagawa T, Nakagawa N, Volkman DJ, Fauci AS (1986) Sequential synergistic effect of interleukin 2 and interferon-γ on the differentiation of a Tac-antigen-positive B cell line. J Immunol 136: 164–168
Grabstein K, Dower S, Urdal D, Larsen A (1986) Expression of interleukin 2, interferon-γ, and the IL-2 receptor by human peripheral blood lymphocytes. J Immunol 136: 4503–4508
Ochoa AC, Hasz DE, Rezonzew R, Anderson PM, Bach FH (1989) Lymphokine-activated killer activity in long-term cultures with anti-CD3 plus interleukin 2: Identification and isolation of effector subsets. Cancer Res 49: 963–968
Kato I, Yokokura T, Mutai M (1988) Correlation between increase in Ia-bearing macrophages and induction of T cell dependent antitumor activity by Lactobacillus casei in mice. Cancer Immunol Immunother 26: 215–221
Sone S, Inamura N, Nii A, Ogura T (1988) Heterogeneity of human lymphokine (IL-2)-activated killer (LAK) precursors and regulation of their LAK induction by blood monocytes. Int J Cancer 42: 428–434
Miyakoshi S, Aoki T (1984) Acting mechanisms of lentinan in human — II. Enhancement of non-specific cell mediated cytotoxicity as an interferon inducer. Int J Immunopharmacol 6: 373–379
About this article
Cite this article
Tani, M., Tanimura, H., Yamaue, H. et al. In vitro generation of activated natural killer cells and cytotoxic macrophages with lentinan. Eur J Clin Pharmacol 42, 623–627 (1992). https://doi.org/10.1007/BF00265926
- Natural killer cell
- cytolytic activity
- cytotoxic macrophage
- in vitro